Jianfen Chen

Jianfen Chen has a diverse and extensive work experience in the field of biostatistics. Jianfen is currently working as a Director of Biostatistics at Arcus Biosciences. Prior to this, they held the position of Associate Director of Biostatistics at Turning Point Therapeutics from 2021 to 2023.

Before that, they worked at Intercept Pharmaceuticals as an Associate Director of Biostatistics from 2020 to 2021, and as a Senior Manager of Biostatistics from 2018 to 2020. Jianfen also worked as a Principal Biostatistician at Prothena Corporation plc from 2017 to 2018.

Earlier in their career, they gained experience as a Senior Biostatistician at Intercept Pharmaceuticals from 2015 to 2017 and at PPD from 2014 to 2015. Jianfen also worked as a Biostatistician I/II and a Statistical Programmer at Synteract from 2010 to 2014.

Prior to joining the industry, Jianfen worked as a consultant in clinical data analysis at Amylin Pharmaceuticals in 2010 and as a Clinical Research Associate at The Scripps Research Institute from 2008 to 2010. Throughout their career, they have been involved in various phases of clinical trials and has expertise in multiple therapeutic areas. Jianfen is highly skilled in statistical analysis and has experience with SAS, Macro, Stat, ODS, and Graph.

Jianfen Chen earned a master's degree in statistics from San Diego State University in the years 2005-2009. Prior to that, there is no available information about their education.